265 related articles for article (PubMed ID: 12218500)
1. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale.
Galer BS; Jensen MP; Ma T; Davies PS; Rowbotham MC
Clin J Pain; 2002; 18(5):297-301. PubMed ID: 12218500
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
3. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale.
Gammaitoni AR; Galer BS; Onawola R; Jensen MP; Argoff CE
Curr Med Res Opin; 2004; 20 Suppl 2():S13-9. PubMed ID: 15563742
[TBL] [Abstract][Full Text] [Related]
4. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale.
Jensen MP; Dworkin RH; Gammaitoni AR; Olaleye DO; Oleka N; Galer BS
J Pain; 2005 Feb; 6(2):98-106. PubMed ID: 15694876
[TBL] [Abstract][Full Text] [Related]
5. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia.
Rowbotham MC; Davies PS; Verkempinck C; Galer BS
Pain; 1996 Apr; 65(1):39-44. PubMed ID: 8826488
[TBL] [Abstract][Full Text] [Related]
6. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain.
Galer BS; Gammaitoni AR; Oleka N; Jensen MP; Argoff CE
Curr Med Res Opin; 2004; 20 Suppl 2():S5-12. PubMed ID: 15563741
[TBL] [Abstract][Full Text] [Related]
7. Introduction: chronic pain studies of the lidocaine patch 5% using the Neuropathic Pain Scale.
Jensen MP
Curr Med Res Opin; 2004; 20 Suppl 2():S1-4. PubMed ID: 15563740
[TBL] [Abstract][Full Text] [Related]
8. Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale.
Argoff CE
Curr Med Res Opin; 2004; 20 Suppl 2():S29-31. PubMed ID: 15563744
[TBL] [Abstract][Full Text] [Related]
9. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.
Davies PS; Galer BS
Drugs; 2004; 64(9):937-47. PubMed ID: 15101784
[TBL] [Abstract][Full Text] [Related]
10. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.
Galer BS; Rowbotham MC; Perander J; Friedman E
Pain; 1999 Apr; 80(3):533-538. PubMed ID: 10342414
[TBL] [Abstract][Full Text] [Related]
11. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R
Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
[TBL] [Abstract][Full Text] [Related]
12. Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study.
Lin PL; Fan SZ; Huang CH; Huang HH; Tsai MC; Lin CJ; Sun WZ
Reg Anesth Pain Med; 2008; 33(4):320-5. PubMed ID: 18675742
[TBL] [Abstract][Full Text] [Related]
13. Topical lidocaine gel relieves postherpetic neuralgia.
Rowbotham MC; Davies PS; Fields HL
Ann Neurol; 1995 Feb; 37(2):246-53. PubMed ID: 7847866
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Lidocaine Infusion Treatment for Neuropathic Pain: A Randomized, Double-Blind, and Placebo-Controlled Study.
Kim YC; Castañeda AM; Lee CS; Jin HS; Park KS; Moon JY
Reg Anesth Pain Med; 2018 May; 43(4):415-424. PubMed ID: 29381569
[TBL] [Abstract][Full Text] [Related]
15. Lidocaine patch 5%.
Comer AM; Lamb HM
Drugs; 2000 Feb; 59(2):245-9; discussion 250-1. PubMed ID: 10730547
[TBL] [Abstract][Full Text] [Related]
16. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB).
Cheville AL; Sloan JA; Northfelt DW; Jillella AP; Wong GY; Bearden Iii JD; Liu H; Schaefer PL; Marchello BT; Christensen BJ; Loprinzi CL
Support Care Cancer; 2009 Apr; 17(4):451-60. PubMed ID: 19142669
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study.
Gormsen L; Finnerup NB; Almqvist PM; Jensen TS
Anesth Analg; 2009 Apr; 108(4):1311-9. PubMed ID: 19299805
[TBL] [Abstract][Full Text] [Related]
18. Topical lidocaine for the treatment of postherpetic neuralgia.
Khaliq W; Alam S; Puri N
Cochrane Database Syst Rev; 2007 Apr; (2):CD004846. PubMed ID: 17443559
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of lidocaine in patients receiving palliative care with opioid-refractory cancer pain with a neuropathic component: study protocol for a randomized controlled study.
Salas S; Auquier P; Duffaud F; Garnier SR; Deschamps M; Honoré S; Sudour P; Baumstarck K
Trials; 2014 Aug; 15():318. PubMed ID: 25112302
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of 5% lidocaine-medicated plaster on localized neuropathic pain after knee surgery: a randomized, double-blind controlled trial.
Pickering G; Voute M; Macian N; Ganry H; Pereira B
Pain; 2019 May; 160(5):1186-1195. PubMed ID: 31009419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
